Home›Companies›Biotech & Pharma›iXpressGenes

iXpressGenes, Inc.

Updated Oct 29, 2026·Latest SEC filing Jun 26, 2025·Suggest an edit

About iXpressGenes

iXpressGenes is a private company based in Huntsville, Alabama. It has reported $2,370,000 raised in one offering on Form D since June 2025. Its chief executive is John Schmitt.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 16, 2009Jun 26, 2025$2,370,000of $4.1M target13$182KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on iXpressGenes's Form D filed Jun 26, 2025.

PS
Peggy Sammon
Director
Also CEO and director at GeneCapture.
JS
John Schmitt
CEO and director
BF
Barbara Fisk
Director
JN
Joseph Ng
Executive officer and director

Sources

  1. SECiXpressGenes, Inc. filing history